相关实验视频

Updated: May 27, 2025

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

4.8K

DDX59-AS1:在肺腺癌中,一种新的预后生物标志物和免疫治疗预测剂

Yanli Wang1, Wei Li2, Su Wei1

  • 1Department of Respiratory and Critical Medicine, First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, Jiangsu, China.

Current medicinal chemistry
|February 20, 2025
PubMed
概括

增加DDX59反感RNA 1 (DDX59-AS1) 表达与肺腺癌 (LUAD) 的预后不佳有关. 这项研究表明,DDX59-AS1可能在LUAD患者中作为预后标记物和潜在的免疫治疗预测剂.

关键词:
在DDX59-AS1中使用.生物标志物生物标志物细胞质DNA传感途径.细胞质DNA传感途径.免疫透 免疫透是什么?肺部腺癌的癌症.预后 预后 预后

更多相关视频

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.3K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K

相关概念视频

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K